Additional file 5: Table S2. of Umeclidinium/vilanterol versus fluticasone propionate/salmeterol in COPD: a randomised trial

Results from the analyses reporting proportions of patients achieving lung function improvements for selected other endpoints (ITT population). (DOC 37 kb)